Parenteral replacement therapy with iron dextran or ferumoxytol in patients with iron deficiency
In patients with iron deficiency, the change of the hematological parameters after replacement therapy was not statistically different between iron dextran and ferumoxytol. Our data suggests that these two formulations have similar efficacy and safety after the IV administration of equivalent doses.
Authors
- Giampaolo Talamo (ORCID: https://orcid.org/0009-0000-1781-1633)
- Marcelle Meseeha (ORCID: https://orcid.org/0000-0001-7976-8415)
- Sundeep Bekal
- Rintaro Onishi
- Muneer Khan
- Rahul Kumar Anand (ORCID: https://orcid.org/0000-0002-7852-1231)
- Kelly L. Wurzler
- Joseph Kuruvilla
Publication Details
- Journal
- International Journal of Clinical Pharmacology and Therapeutics
- Published
- 2025-12-30
- DOI
- https://doi.org/10.5414/cp204904
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00